Form EFFECT Cyclerion Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 24, 2026 4:00 P.M. |
| Form: | S-4 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golden Arrow Announces Filing of Its Meeting Materials in Connection with Its Annual General and Special Meeting to Approve Sale of Copper Assets at San Pietro Project
- Qnity Receives Zhen Ding 2026 Distinguished Contribution Award
- Keel Infrastructure Schedules Second Quarter 2026 Conference Call on August 10, 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
